Longwood Capital Partners as of Sept. 30, 2015
Portfolio Holdings for Longwood Capital Partners
Longwood Capital Partners holds 59 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amicus Therapeutics (FOLD) | 11.4 | $20M | 1.4M | 13.99 | |
| Exelixis (EXEL) | 6.1 | $11M | 1.9M | 5.61 | |
| Neuroderm Ltd F | 5.9 | $10M | 497k | 20.67 | |
| Ascendis Pharma A S (ASND) | 4.8 | $8.3M | 470k | 17.70 | |
| iShares Russell 2000 Index (IWM) | 4.4 | $7.6M | 70k | 109.21 | |
| Lion Biotechnologies | 4.4 | $7.6M | 1.3M | 5.76 | |
| Biotelemetry | 3.2 | $5.5M | 450k | 12.24 | |
| Cynapsus Therapeutics | 2.9 | $5.1M | 314k | 16.17 | |
| SPDR S&P Biotech (XBI) | 2.5 | $4.4M | 70k | 62.24 | |
| Lexicon Pharmaceuticals (LXRX) | 2.5 | $4.3M | 400k | 10.74 | |
| Veracyte (VCYT) | 2.5 | $4.2M | 905k | 4.69 | |
| Rrsat Global Comm Ntwrk | 2.2 | $3.8M | 469k | 8.20 | |
| Pernix Therapeutics Holdings | 2.0 | $3.5M | 1.1M | 3.16 | |
| Innocoll | 2.0 | $3.4M | 274k | 12.52 | |
| La Jolla Pharmaceuticl Com Par | 2.0 | $3.4M | 122k | 27.79 | |
| Nabriva Therapeutics | 1.9 | $3.3M | 351k | 9.50 | |
| WebMD Health | 1.8 | $3.2M | 80k | 39.84 | |
| CAS Medical Systems | 1.8 | $3.2M | 2.5M | 1.25 | |
| BioCryst Pharmaceuticals (BCRX) | 1.8 | $3.1M | 271k | 11.40 | |
| Spectranetics Corporation | 1.8 | $3.1M | 260k | 11.79 | |
| Spectranetics Corp mtnf 2.625% 6/0 | 1.8 | $3.0M | 4.0M | 0.76 | |
| IRIDEX Corporation (IRIX) | 1.8 | $3.0M | 397k | 7.61 | |
| Immunomedics | 1.7 | $2.9M | 1.7M | 1.72 | |
| Applied Genetic Technol Corp C | 1.7 | $2.9M | 221k | 13.14 | |
| Build-A-Bear Workshop (BBW) | 1.7 | $2.9M | 153k | 18.89 | |
| Sagent Pharmaceuticals | 1.6 | $2.8M | 183k | 15.33 | |
| Sorrento Therapeutics (SRNEQ) | 1.5 | $2.5M | 300k | 8.39 | |
| Oxford Immunotec Global | 1.4 | $2.5M | 185k | 13.50 | |
| Agenus (AGEN) | 1.4 | $2.3M | 510k | 4.60 | |
| Array BioPharma | 1.3 | $2.2M | 480k | 4.56 | |
| Alimera Sciences | 1.2 | $2.2M | 974k | 2.21 | |
| Axovant Sciences | 1.1 | $1.8M | 140k | 12.92 | |
| Epizyme | 1.0 | $1.8M | 140k | 12.86 | |
| Essa Pharma | 1.0 | $1.8M | 288k | 6.23 | |
| Zafgen | 0.9 | $1.6M | 52k | 31.95 | |
| Cutera (CUTR) | 0.9 | $1.5M | 117k | 13.08 | |
| Carrols Restaurant (TAST) | 0.9 | $1.5M | 129k | 11.90 | |
| Clovis Oncology | 0.8 | $1.4M | 15k | 91.93 | |
| BioDelivery Sciences International | 0.7 | $1.2M | 212k | 5.56 | |
| Biodel | 0.7 | $1.1M | 2.5M | 0.44 | |
| Aurinia Pharmaceuticals (AUPH) | 0.6 | $1.1M | 377k | 2.84 | |
| Flex Pharma | 0.6 | $1.1M | 89k | 12.00 | |
| Sarepta Therapeutics (SRPT) | 0.6 | $1.0M | 32k | 32.10 | |
| Combimatrix Corporation | 0.6 | $1.0M | 894k | 1.12 | |
| Agile Therapeutics | 0.6 | $952k | 141k | 6.74 | |
| iShares MSCI Australia Index Fund (EWA) | 0.5 | $896k | 50k | 17.92 | |
| Celladon | 0.5 | $861k | 820k | 1.05 | |
| Cardiome Pharma | 0.5 | $780k | 92k | 8.44 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.4 | $752k | 59k | 12.72 | |
| Rigel Pharmaceuticals (RIGL) | 0.3 | $494k | 200k | 2.47 | |
| Cardica | 0.3 | $499k | 1.8M | 0.27 | |
| Histogenics Corp Cmn | 0.3 | $491k | 123k | 3.98 | |
| Abeona Therapeutics | 0.3 | $451k | 111k | 4.05 | |
| Cempra | 0.2 | $418k | 15k | 27.87 | |
| Organovo Holdings | 0.2 | $322k | 120k | 2.68 | |
| Arrowhead Research | 0.2 | $288k | 50k | 5.76 | |
| Zosano Pharma | 0.2 | $292k | 74k | 3.96 | |
| Kindred Biosciences | 0.1 | $260k | 50k | 5.20 | |
| Accelr8 Technology | 0.1 | $243k | 15k | 16.20 |
